EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Pharmacological and Biological Targeting of FGFR1 in Cancer

Shuai Fan, Yuxin Chen, Wenyu Wang, Wanting Xu, Mei Tian, Yuetong Liu, Yutong Zhou, Dan Liu, Qin Xia iD, Lei Dong iD

Current Issues in Molecular Biology · 18.11.2024 · 46 (11) · 13131-13150

DOI: 10.3390/cimb46110783 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 18.11.2024. Verfasst von Shuai Fan und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Molecular Medicine and Biological Diagnosis and Treatment (Ministry of Industry and Information Technology), School of Life S…. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundamental Research Funds for the Central Universities, Beijing Municipal Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

FGFR1 is a key member of the fibroblast growth factor receptor family, mediating critical signaling pathways such as RAS-MAPK and PI3K-AKT. which are integral to regulating essential cellular processes, including proliferation, differentiation, and survival. Alterations in FGFR1 can lead to constitutive activation of signaling pathways that drive oncogenesis by promoting uncontrolled cell division, inhibiting apoptosis, and enhancing the metastatic potential of cancer cells. This article reviews the activation mechanisms and signaling pathways of FGFR1 and provides a detailed exposition of the types of FGFR1 aberration. Furthermore, we have compiled a comprehensive overview of current therapies targeting FGFR1 aberration in cancer, aiming to offer new perspectives for future cancer treatments by focusing on drugs that address specific FGFR1 alterations.

Schlagwörter

Stichwörter der Autor:innen

FGFR1TKIaberrationantibody drugsligand trapstargeted therapeutics

Autor:innen und Institutionen

  • State Key Laboratory of Molecular Medicine and Biological Diagnosis and Treatment (Ministry of Industry and Information Technology), School of Life Science, Beijing Institute of Technology, Beijing 100081, China.

ORCID-Profile: Qin Xia, Lei Dong

Förderung

  • Fundamental Research Funds for the Central Universities
  • Beijing Municipal Natural Science Foundation

Zitieren

APA

Fan, S., Chen, Y., Wang, W., Xu, W., Tian, M., Liu, Y., Zhou, Y., Liu, D., Xia, Q., & Dong, L. (2024). Pharmacological and Biological Targeting of FGFR1 in Cancer. Current Issues in Molecular Biology, 46(11), 13131-13150. https://doi.org/10.3390/cimb46110783

Vancouver

Fan S, Chen Y, Wang W, Xu W, Tian M, Liu Y, et al. Pharmacological and Biological Targeting of FGFR1 in Cancer. Current Issues in Molecular Biology. 2024;46(11):13131-13150. doi:10.3390/cimb46110783

BibTeX
@article{Fan2024,
  author = {Fan, Shuai and Chen, Yuxin and Wang, Wenyu and Xu, Wanting and Tian, Mei and Liu, Yuetong and Zhou, Yutong and Liu, Dan and Xia, Qin and Dong, Lei},
  title = {Pharmacological and Biological Targeting of FGFR1 in Cancer},
  journal = {Current Issues in Molecular Biology},
  year = {2024},
  volume = {46},
  number = {11},
  pages = {13131--13150},
  doi = {10.3390/cimb46110783}
}
Kostenlos starten →